Industry News
PEG Based Hydrogels for Medical Devices
Several leading companies worldwide have introduced medical devices based on PEG hydrogel.
Myasthenia Gravis (MG) Treatments - FcRn …
Now, there 5 approved drugs for the treatment of Myasthenia Gravis.
What is the difference between siRNA and …
On October 7, 2024, the Nobel Prize in Physiology or Medicine was awarded to Professor Victor Ambros from the University of Massachusetts Medical School and Professor Gary Ruvkun from Harvard…
Use of Monodisperse PEGs to Accelerate Dr…
Monodisperse PEG, which consists of uniform molecules with precise, discrete molecular weights and well-defined configurations, offers a solution to these issues.
Latest Clinical Data on Obesity Drugs and…
Next, we will focus on the latest clinical data for obesity drugs and provide a comprehensive overview of available weight loss medications.
Overview of Long Acting Growth Hormone Fo…
Developing long-acting growth hormone (LAGH) formulations to improve adherence and treatment outcomes has become a primary focus.
Dual/Triple-Agonists Targeting GLP-1R
The success of tirzepatide has made GLP-1 dual/triple agonists a hot area of competition.
New Advances of Antibody-Drug Conjugates …
Among the many ADCs in development, several companies are actively seeking unique breakthroughs to stand out. Lets explore these companies innovative approaches.
FDA Approved Treatments for Geographic At…
Pegcetacoplan (Syfovre) and Avacincaptad pegol (Izervay) are currently the only approved treatments for GA, but there is still room for improvement in their efficacy.
Application of PEG Derivatives in ADC Lin…
PEG Linker is one of the most widely used linkers in ADCs, which can increase the water solubility, improve the DAR value and increase the cycle half-life of ADCs.
sales@huatengusa.com
+86 0731 89916275